|
[Lys(Me1)9]-Histone H3 (1-21)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Me2)79]-Histone H3 (69-89)-K(Biotin) - 0.25 mg
|
|
|
|
[Lys(Me1)4]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Ser25]-PKC (19-31), biotinylated - 1 mg
|
|
177966-62-0
|
|
[Lys(Me1)4]-Histone H3 (1-21)-GGK(FAM)-NH2 - 1 mg
|
|
|
|
[Lys(Me2)4]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
43Gap 27, Connexin (200-210) (human, mouse, rat) - 1 mg
|
|
198284-64-9
|
|
490 MMP Substrate XVI (TNO211) - 1 mg
|
|
193475-71-7
|
|
[Lys(Me2)20]-Histone H4 (8-30)-WGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)20]-Histone H4 (1-23)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[pSer10]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
40Gap 27, Connexin Mimetic - 1 mg
|
|
|
|
4N1K Cell binding Domain Adhesive Peptide - 1 mg
|
|
|
|
[Lys(Me1)4]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Lys22]-beta-Amyloid (1-40), Italian Mutation - 0.5 mg
|
|
302905-01-7
|
|
1-Pyrenebutanoic acid, succinimidyl ester - 100 mg
|
|
|
|
[Lys(Me2)9]-Histone H3 (3-17) - 1 mg
|
|
|
|
[Lys(Me3)9]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Me2)27]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
[Lys(Me2)4]-Histone H3 (1-10) - 1 mg
|
|
|
|
[Met]-beta-Amyloid (1-42), 5-TAMRA labeled - 0.1 mg
|
|
|
|
[Met5]-Enkephalin - 25 mg
|
|
58569-55-4
|
|
[Thr28, Nle31]-Cholecystokinin (25-33), sulfated CCK-9 - 1 mg
|
|
77568-41-3
|
|
[Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
[Lys(Me3)9]-Histone H3 (3-17) - 1 mg
|
|
|
|
390 MMP Substrate XIII, NFF-3 - 1 mg
|
|
158584-09-9
|
|
4-Nitrophenyl-N-acetyl--D-galactosaminide - 100 mg
|
|
14948-96-0
|
|
[Lys(Me2)27,Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin) - 1 mg
|
|
|
|
[Lys(Me2)9]-Histone H3 (1-21)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)36]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
[Lys(Me3)36]-Histone H3 (31-41) - 1 mg
|
|
|
|
[Met(O)35]-beta-Amyloid (1-42) - 0.5 mg
|
|
1802086-68-5
|
|
[Lys0]-Bradykinin (Kallidin) - 5 mg
|
|
342-10-9
|
|
[Pro19]-beta-Amyloid (1-42) - 1 mg
|
|
|
|
390 MMP FRET Substrate XI - 5 mg
|
|
|
|
5(6)-CFDA, SE [5(6)-Carboxyfluorescein diacetate, SE] Fluorescent pH Indicator - 25 mg
|
|
150347-59-4
|
|
37, 40Gap 26, Connexin Mimetic - 1 mg
|
|
|
|
[Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
26Rfa, Hypothalamic Peptide, rat - 1 mg
|
|
600171-70-8
|
|
[Lys(Me1)27]-Histone H3 (23-34) - 1 mg
|
|
|
|
[Lys(Me2)20]-Histone H4 (1-23)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Pyr1]-Apelin-13 - 1 mg
|
|
217082-60-5
|
|
[Lys(Me1)9]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Me3)4]-Histone H3 (1-25)-NH2 - 1 mg
|
|
|
|
[Lys(Me1)36]-Histone H3 (31-41) - 1 mg
|
|
|
|
390 MMP FRET Substrate 5 - 1 mg
|
|
891198-38-2
|
|
5(6)-CR110 [5-(and-6)-Carboxyrhodamine 110, hydrochloride] - 25 mg
|
|
116763-35-0
|
|
[Lys(Me2)4]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Me3)4]-Histone H3 (1-21)
|
|
|
|
0.45M HBTU/HOBT in DMF - 200 mL
|
|
|
|
[Lys(Me2)36]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
[Lys(Me1)27]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
390 MMP FRET Substrate 2 - 5 mg
|
|
|
|
[Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Me1)9]-Histone H3 (3-17) - 1 mg
|
|
|
|
[Pyr11]-beta-Amyloid (11-42)
|
|
|
|
[Pyr3]-beta-Amyloid (3-42)
|
|
183449-57-2
|
|
[Lys(Me1)27/36]-Histone H3 (21-44)-GK(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
1 - Hydroxybenzotriazole hydrate (HOBt hydrate)
|
|
123333-53-9
|
|
[Lys(Me2)27]-Histone H3 (23-34) - 1 mg
|
|
|
|
[pSer10), Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin) - 0.25 mg
|
|
|
|
[Lys(Me3)4]-Histone H3 (1-10) - 1 mg
|
|
|
|
[Lys3]-Bombesin - 5 mg
|
|
66839-66-5
|
|
[Lys(Me1)36]-Histone H3 (26-46)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)27]-Histone H3 (23-34) - 1 mg
|
|
|
|
[Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
26Rfa, Hypothalamic Peptide, human - 1 mg
|
|
600171-68-4
|
|
[pSer28]-Histone H3 (21-44)-GK (Biotin) - 1 mg
|
|
|
|
2-ClTrt resin - 5 g
|
|
|
|
[Lys(Me3)27]-Histone H3 (23-34)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me1)79]-Histone H3 (69-89)-K(Biotin) - 0.25 mg
|
|
|
|
[Lys(Me2)36]-Histone H3 (31-41) - 1 mg
|
|
|
|
[Succinyl-Asp6, NMePhe8]-Substance P (6-11), Senktide - 5 mg
|
|
106128-89-6
|
|
[Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Lys(Me3)27]-Histone H3 (21-44)-GK(Biotin)
|
|
|
|
[Pro18]-beta-Amyloid (12-28) - 1 mg
|
|
|
|
[Lys8,9]-Neurotensin (8-13) - 5 mg
|
|
139026-64-5
|
|
[Trp63, 64]-C3a (63-77) - 1 mg
|
|
130154-64-2
|
|
[Lys(Me2)9]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Me2)18]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[pThr11]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Pyr3]-beta-Amyloid (3-40)
|
|
161818-04-8
|
|
[Lys(Me3)4,Lys(Ac)9,pSer10]-Histone H3 (1-21) - 1 mg
|
|
|
|
43Gap 27, Connexin (200-210) (human, mouse, rat) scrambled - 1 mg
|
|
|
|
490 MMP FRET Substrate X - 1 mg
|
|
|
|
[Lys(Me3)79]-Histone H3(73-83) - 1 mg
|
|
|
|
390 MMP FRET Substrate 1 - 1 mg
|
|
140430-53-1
|
|
[Lys(Me3)20]-Histone H4 (8-30)-WGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me1)4]-Histone H3 (1-10) - 1 mg
|
|
|
|
1 % NH4OH solution - 300 μl
|
|
|
|
[Lys(Me2)36]-Histone H3 (26-46)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Me3)79]-Histone H3 (69-89)-K(Biotin) - 0.25 mg
|
|
|
|
[Lys22]-beta-Amyloid (1-42), Italian Mutation - 0.5 mg
|
|
|
|
[Pyr11]-beta-Amyloid (11-40) - 1 mg
|
|
192377-94-9
|
|
5-FAM [5-Carboxyfluorescein]
|
|
76823-03-5
|